Hanmi Pharma wins South Korea approval for Efpe auto-injector obesity drug
Bitget2026/10/07 09:56South Korea’s MFDS granted marketing authorization for Hanmi Pharmaceutical’s Efpeo Auto-Injector (efpeglenatide), an obesity drug for chronic weight management. Approval covers five strengths; indicated for adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity. Authorization date Oct. 7, 2026; Hanmi targets domestic launch by year-end. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanmi Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261007800667), on October 07, 2026, and is solely responsible for the information contained therein.
- South Korea’s MFDS granted marketing authorization for Hanmi Pharmaceutical’s Efpeo Auto-Injector (efpeglenatide), an obesity drug for chronic weight management.
- Approval covers five strengths; indicated for adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity.
- Authorization date Oct. 7, 2026; Hanmi targets domestic launch by year-end.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pendle Bridge integrates with BungeeExchange, supporting cross-chain transfers across 13 networks
Barclays significantly increased holdings in Tesla (TSLA.US) and Intel (INTC.US) in Q3, and bought Nasdaq ETF options for hedging
According to disclosures by the U.S. Securities and Exchange Commission (SEC), Barclays has submitted its third-quarter holdings report (13F) as of September 30, 2026.
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Crypto prices
More
